Crystalline forms of a brutons tyrosine kinase inhibitor | Patent Number 10125140

US 10125140 B1
Application Number16036258
Publication NumberUS 20180319806 A1
Pendency4 months
Filled DateJul 16, 2018
Priority DateJun 4, 2012
Publication DateNov 8, 2018
Expiration DateJun 3, 2032
Inventor/ApplicantsMark S. Smyth
Erick Goldman
Norbert Purro
David D. Wirth
ExaminesHENLEY III, RAYMOND J
Art Unit1629
Technology Center1600
Assignments
Pharmacyclics
Current
PharmacyclicsAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.